|
|
 |
|
Viewing report
|
|
|
|
Company Financials: Cypress Bioscience, Inc.
Datamonitor, Jan 2010
The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .
Scope
- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation
- Provides key ratios
- Includes information on revenue distribution by business segments and geographies
Highlights of this title
Cypress Bioscience (Cypress) is engaged in providing therapeutics and personalized medicine services to facilitate improved and individualized patient care. The company focuses on the areas of pain, rheumatology, and physical medicine and rehabilitation, including challenging disorders such as fibromyalgia and rheumatoid arthritis.
Key reasons to purchase this title
- Access important financial information and analysis on the company in a single datapack
- Understand the financial evolution of the five company over the last years.
- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization
Customers who bought this item also bought
Company Financials: Genzyme Corporation
Company Financials: Regeneron Pharmaceuticals, Inc.
Company Financials: Genta Incorporated
Company Financials: Gilead Sciences, Inc.
Company Financials: Infinity Pharmaceuticals
Company Financials: Neurocrine Biosciences, Inc.
Company Financials: Sangamo Biosciences, Inc.
Company Financials: Martek Biosciences Corporation
Company Financials: Labopharm Inc.
Company Financials: Eli Lilly and Company
|
|
|
|
